Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Stocks
CFD
Stock CFD Derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
3.8%
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Earn
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
tag
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Others
TradFi（新）
2026 World Cup
Rewards
Square
Latest
Hot
News
Profile
Winner666

Intuitive Surgical (ISRG), the parent company of the da Vinci surgical robot, disclosed in its latest quarterly report that the global number of da Vinci procedures in the second quarter slowed in growth. Combined with pressure on gross margin from supply-chain and R&D costs, institutional investors quickly began reassessing its high price-to-earnings multiple (P/E) and lowering its valuation.



Shares plunged nearly 12.8% during the session, dragging down the medical device and high-growth technology segments.
‍#PreIPOs第二期OpenAI认购
ISRG-14.16%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 5
  • Repost
  • Share
Comment
Add a comment
Add a comment
GasDetective
· 3h ago
The slowdown in growth is expected, but the market reaction is a bit overblown.
View OriginalReply0
ConvertibleArb
· 4h ago
The technical barriers of the Da Vinci robot are indeed high, but the valuation is also high. Once its growth rate falls short of expectations, the valuation gets hit hard—so this pullback may well be an opportunity, but it depends on whether the subsequent surgical volume can rebound.
View OriginalReply0
RetailSpokesperson
· 4h ago
This drop is a bit scary, but think about how much it rose before—pullbacks are also healthy. The key is to see whether the growth rate in next quarter’s procedure volume can stay stable.
View OriginalReply0
PFPSurgeon
· 4h ago
As competition in the surgical robotics sector grows increasingly fierce, Medtronic and Johnson & Johnson are also laying out their plans. ISRG’s monopolistic position is beginning to loosen, and with rising R&D costs, gross margins are under pressure—so it’s also normal to see some institutions pulling out. However, in the long run, the da Vinci’s position in minimally invasive surgery is still very difficult to replace.
View OriginalReply0
MacroElk
· 4h ago
A high price-to-earnings ratio is a double-edged sword: it feels great when prices rise, and it’s brutal when they fall.
View OriginalReply0

  • Pinned

Sitemap